BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Comtess (entacapone) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Comtess (entacapone)\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT04246437-1761@assetmemo.bio
DTSTAMP:20261121T004040Z
DTSTART;VALUE=DATE:20270201
DTEND;VALUE=DATE:20270202
SUMMARY:Comtess (entacapone): Phase 1 readout est. (NCT04246437)
DESCRIPTION:Comtess (entacapone)\, phase 1\, Parkinson's Disease.\nStudy: [
 18F]F-DOPA Imaging in Patients With Autonomic Failure\nEstimated primary c
 ompletion: 1 February 2027. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/entacapone#upcoming-events\nRegistry record: https://clinicaltrials
 .gov/study/NCT04246437
URL:https://assetmemo.bio/drug/entacapone#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07831187-1761@assetmemo.bio
DTSTAMP:20261121T004040Z
DTSTART;VALUE=DATE:20290930
DTEND;VALUE=DATE:20291001
SUMMARY:Comtess (entacapone): Phase 1/2 readout est. (NCT07831187)
DESCRIPTION:Comtess (entacapone)\, phase 1/2.\nStudy: Entacapone Plus Bevac
 izumab for Glioblastoma at First Recurrence\nEstimated primary completion:
  30 September 2029. This is a ClinicalTrials.gov estimate\, not a confirme
 d readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/e
 ntacapone#upcoming-events\nRegistry record: https://clinicaltrials.gov/stu
 dy/NCT07831187
URL:https://assetmemo.bio/drug/entacapone#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT00262470-1761@assetmemo.bio
DTSTAMP:20261121T004040Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:Comtess (entacapone): Phase 1/2 readout est. (NCT00262470)
DESCRIPTION:Comtess (entacapone)\, phase 1/2.\nStudy: Treatment of Orthosta
 tic Intolerance\nEstimated primary completion: December 2029. This is a Cl
 inicalTrials.gov estimate\, not a confirmed readout date\, and it can move
 .\nDrug page: https://assetmemo.bio/drug/entacapone#upcoming-events\nRegis
 try record: https://clinicaltrials.gov/study/NCT00262470
URL:https://assetmemo.bio/drug/entacapone#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
